Can I Continue My Current GLP-1 Dose at Join Luma?

Start at intake.joinluma.com and explain that you already take a GLP-1 medication. List the exact medication name, brand or compounded status, injection or oral formulation, prescribed dose in milligrams, dosing frequency and date of your last dose. Describe recent missed doses instead of reporting only your usual weekly schedule.

Include a current medication list, diagnoses, allergies and any side effects. If your prescription is compounded, the pharmacy name, concentration and directions help distinguish the actual dose from syringe markings. Keep a label photo available if the clinician requests it. Learn how to sign up, but do not stop, overlap or change existing treatment solely because you have submitted a new intake.

Medical care is provided by Arora Health and Aesthetics, and a licensed clinician reviews every intake before prescribing. They consider your treatment history, tolerability, response, other medicines and any interruption. Approval is not based simply on the amount you say you want to continue. You are charged only if a clinician approves treatment.

A clinician may continue the dose, recommend an adjustment, request more information or determine that the proposed treatment is not appropriate. Previous tolerance is useful information, but it does not erase new symptoms, pregnancy plans or a long gap. Be specific about what happened at each dose: whether you could eat and drink normally, whether symptoms resolved, and whether another prescriber changed the schedule.

The fetched Wegovy prescribing information directs reinitiating escalation at a lower dose if two or more consecutive Wegovy injection doses are missed, to reduce gastrointestinal adverse-reaction risk. This is a brand-product instruction, not permission to select your own lower compounded dose. Tell your clinician exactly when the last dose occurred and how many scheduled injections were missed.

Older label versions may word restart guidance differently, so a remembered instruction or saved screenshot may not match the current prescribing information. Use the guidance for your actual prescription and ask your clinician about any conflict. A two-week gap can be clinically important, but calendar time alone does not establish the right restart dose for a different medication or formulation.

No universal two-week restart schedule is specified in the fetched Zepbound prescribing information. Its missed-dose guidance says to take a missed dose within four days, or skip it if more than four days have passed and resume the regularly scheduled day. It also requires at least three days between doses when changing the administration day.

Those instructions address a missed dose; they do not provide a blanket rule to resume any prior high dose after multiple missed weeks. Ask your clinician about a longer interruption and do not apply Wegovy’s restart wording to tirzepatide. See the missed-dose guide for questions to bring to your care team, not a substitute restart prescription.

The FDA’s dosing-error alert describes mistakes involving different concentrations and confusion between milligrams, milliliters and syringe units. Read the label on each new vial, even when the medication name looks familiar. Ask the clinician or dispensing pharmacy to confirm any measurement you cannot confidently explain back.

The arithmetic is volume in mL = dose in mg divided by concentration in mg/mL. On a U-100 syringe only, one mL corresponds to 100 units, so the example volumes would be 40 and 20 units. Do not use these examples as your own directions. Confirm your actual label, syringe type and measurement with the pharmacy before injecting; another concentration or syringe requires different instructions.

The Wegovy prescribing information and Zepbound prescribing information describe FDA-approved brand products, not Join Luma’s compounded medications. Their schedules provide useful context, but your own prescription label and Join Luma clinician determine your instructions. Do not copy a brand pen schedule onto an injection vial or a once-daily dissolving tablet.

There is no automatic milligram-for-milligram conversion between semaglutide and tirzepatide or between injections and oral ODT tablets. Tell the clinician whether you want to maintain a familiar treatment or discuss a different format. Join Luma’s oral ODT tablets are once daily and built in with ondansetron for anti-nausea support; injections are weekly.

Ask for a clear transition plan, including which medicine to stop, when the next medicine starts and what dose applies. Do not run old and new prescriptions in parallel unless your clinician specifically directs the treatment plan. Keep pharmacy instructions for the new product separate from remaining supplies to reduce the chance of using outdated directions.

Current GLP User monthly pricing is $149 for compounded semaglutide or $219 for compounded tirzepatide. Six-month prepaid injection plans are $99/month for semaglutide, $594 total, or $149/month for tirzepatide, $894 total. Affirm, Klarna or Afterpay can split the payment, subject to approval. Compare commitment lengths and oral ODT options on Join Luma’s pricing page.

There are no membership fees. Plans include clinician oversight, medication if prescribed, necessary supplies and shipping, and the price stays the same at every dose within the plan. That means a prescribed dose increase does not itself raise the plan price; it does not mean switching medication or commitment length leaves billing unchanged.

Six-month plans ship medication in supplies of up to three months rather than necessarily sending the entire six months together. Check shipment timing and cancellation terms before selecting a commitment. Ask support before the next billing date if you want a different plan length, and distinguish a billing change from a clinical decision about the next dose.

Check the medication, pharmacy, concentration, directions and beyond-use date. Match the label to the clinician’s transition plan and resolve any discrepancy before the next dose. A familiar-looking vial or the same number of syringe units is not enough to establish that the prescription is unchanged.

Support is available 24/7 at support@joinluma.com or through the patient portal; most inquiries receive a reply within 1–2 hours. That is a typical support response window, not a guarantee of clinician review or an emergency service. Ask support to help route medical questions to your clinician rather than treating a billing reply as dosing authorization.

Seek urgent care for severe abdominal pain, signs of pancreatitis, significant dehydration, or a serious allergic reaction; call 911 for a life-threatening emergency. Do not wait for a portal reply in an emergency. For nonurgent nausea, constipation, appetite changes or uncertainty about the next dose, contact your clinician for a plan tailored to your symptoms.

Read what changes at refill so that the same label checks become routine at every delivery, not only when transferring into Join Luma.